Paper6132360
Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
Giardini O and 3 others. Pediatr Res, 1983. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement. Papers, record 6132360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6132360
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 4-Hydroxyphenylpyruvate Dioxygenase | Major topic |
| Ataxia | Major topic |
| Liver | Major topic |
| Oxygenases | Major topic |
| Tyrosine | Major topic |
| Chronic Disease | |
| Cytosol | |
| Female | |
| Glutamate Dehydrogenase | |
| Humans | |
| Infant | |
| L-Lactate Dehydrogenase | |
| Mitochondria, Liver | |
| Phosphogluconate Dehydrogenase | |
| Tyrosine Transaminase |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42140431 | Disease associated missense substitutions disrupt structural stability and catalytic function of 4-hydroxyphenylpyruvate dioxygenase. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42140431 | PubMed |
| 36048613 | The Human Glyoxalase Gene Family in Health and Disease. | Chem Res Toxicol | 2022 | https://conductscience.org/library/papers/36048613 | PubMed |
| 35707594 | Novel Cranial Imaging Findings and a Splice-Site Variant in a Patient with Tyrosinemia Type III, and a Summary of Published Cases. | Mol Syndromol | 2022 | https://conductscience.org/library/papers/35707594 | PubMed |
| 32520295 | TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW. | Rev Paul Pediatr | 2020 | https://conductscience.org/library/papers/32520295 | PubMed |
| 29456978 | A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation. | Adv Biomed Res | 2018 | https://conductscience.org/library/papers/29456978 | PubMed |
| 22687740 | Hepatorenal tyrosinemia. | Proc Jpn Acad Ser B Phys Biol Sci | 2012 | https://conductscience.org/library/papers/22687740 | PubMed |
| 16706549 | Nitisinone in the treatment of hereditary tyrosinaemia type 1. | Drugs | 2006 | https://conductscience.org/library/papers/16706549 | PubMed |
| 11916315 | Outcome of tyrosinaemia type III. | J Inherit Metab Dis | 2001 | https://conductscience.org/library/papers/11916315 | PubMed |
| 9728332 | Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report. | J Inherit Metab Dis | 1998 | https://conductscience.org/library/papers/9728332 | PubMed |
| 9728330 | From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug. | J Inherit Metab Dis | 1998 | https://conductscience.org/library/papers/9728330 | PubMed |
| 8598649 | Benign tyrosinaemia: an 18-year follow-up. | J Inherit Metab Dis | 1995 | https://conductscience.org/library/papers/8598649 | PubMed |
| 7474904 | Immunological abnormalities in a patient with tyrosinaemia type III. | J Inherit Metab Dis | 1995 | https://conductscience.org/library/papers/7474904 | PubMed |
| 2246865 | Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III. | J Inherit Metab Dis | 1990 | https://conductscience.org/library/papers/2246865 | PubMed |
| 2014797 | A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia. | Am J Hum Genet | 1991 | https://conductscience.org/library/papers/2014797 | PubMed |
| 1293381 | Autoimmune thyroiditis in a case of tyrosinaemia type III. | J Inherit Metab Dis | 1992 | https://conductscience.org/library/papers/1293381 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HPD | 3242 | PubTator's text mining | https://conductscience.org/library/genes/3242 | NCBI Gene |
| PGD | 5226 | PubTator's text mining | https://conductscience.org/library/genes/5226 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6132360
GET https://conductscience.org/api/papers/v1/6132360/authors